Current prescribing patterns of bupropion in Australia

Christopher M Doran, Anthony P Shakeshaft, Jennifer A Gates, Julia E Fawcett and Richard P Mattick
Med J Aust 2002; 177 (3): . || doi: 10.5694/j.1326-5377.2002.tb04708.x
Published online: 5 August 2002

To the Editor: Bupropion hydrochloride was listed on the Pharmaceutical Benefits Scheme (PBS) on 1 February 2001 for use as short-term adjunctive therapy for high nicotine dependence, with the goal of maintaining abstinence. Supply is limited to one application per year, with no repeats, and a maximum quantity of 120 tablets at a dispensed cost of $238.95.


  • 1. PBS expenditure and prescriptions February 2001 to December 2001. Canberra: Department of Health and Aged Care, 2002. Available at <
  • 2. Australian Institute of Health and Welfare. Health expenditure bulletin no. 17: Australia's health services expenditure to 1999–00. Canberra: AIHW, 2001. (Catalogue No. HWE 18; Health and Welfare expenditure series No. 12.)
  • 3. Australian Institute of Health and Welfare. 1998 National drug strategy household survey: first results. Canberra: AIHW, 1999. (AIHW Catalogue No. PHE 15; Drug Statistics Series.)
  • 4. Australian Bureau of Statistics. Australian population by age and sex, Australian States and Territories. Drug Statistics Series. Canberra: ABS, 2001. (Catalogue no. 3201.0.)
  • 5. Robertson J, Fryer JL, O'Connell DL, et al. Limitations of Health Insurance Commission (HIC) data for deriving prescribing indicators. Med J Aust 2002; 176: 419-424. <MJA full text>


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.